Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Jul;40(7):1754–1756. doi: 10.1128/aac.40.7.1754

Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis.

T R Garbe 1, N S Hibler 1, V Deretic 1
PMCID: PMC163413  PMID: 8807080

Abstract

Exposure to isoniazid induced the expression of several secreted proteins in Mycobacterium tuberculosis H37Rv. Two-dimensional gel electrophoresis and immunoblot analyses indicated that two of the prominent isonicotinic acid hydrazide-inducible polypeptides were members of the antigen 85 complex, recently demonstrated to have mycolyltransferase activity. We postulate the existence of an intermediate, whose production is inhibited by isonicotinic acid hydrazide, which plays a negative feedback regulatory role in the metabolism of mycolic acids are revealed by the overexpression of the antigen 85 complex. The approach described here relies on analyses of differential gene expression following exposure to inhibitors and may become a more general tool in dissecting the effects of antimicrobial agents.

Full Text

The Full Text of this article is available as a PDF (301.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abou-Zeid C., Garbe T., Lathigra R., Wiker H. G., Harboe M., Rook G. A., Young D. B. Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect Immun. 1991 Aug;59(8):2712–2718. doi: 10.1128/iai.59.8.2712-2718.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abou-Zeid C., Ratliff T. L., Wiker H. G., Harboe M., Bennedsen J., Rook G. A. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun. 1988 Dec;56(12):3046–3051. doi: 10.1128/iai.56.12.3046-3051.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andersen A. B., Yuan Z. L., Hasløv K., Vergmann B., Bennedsen J. Interspecies reactivity of five monoclonal antibodies to Mycobacterium tuberculosis as examined by immunoblotting and enzyme-linked immunosorbent assay. J Clin Microbiol. 1986 Mar;23(3):446–451. doi: 10.1128/jcm.23.3.446-451.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Andersen P., Askgaard D., Ljungqvist L., Bennedsen J., Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun. 1991 Jun;59(6):1905–1910. doi: 10.1128/iai.59.6.1905-1910.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bloom B. R., Murray C. J. Tuberculosis: commentary on a reemergent killer. Science. 1992 Aug 21;257(5073):1055–1064. doi: 10.1126/science.257.5073.1055. [DOI] [PubMed] [Google Scholar]
  6. Borremans M., de Wit L., Volckaert G., Ooms J., de Bruyn J., Huygen K., van Vooren J. P., Stelandre M., Verhofstadt R., Content J. Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect Immun. 1989 Oct;57(10):3123–3130. doi: 10.1128/iai.57.10.3123-3130.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Content J., de la Cuvellerie A., De Wit L., Vincent-Levy-Frébault V., Ooms J., De Bruyn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun. 1991 Sep;59(9):3205–3212. doi: 10.1128/iai.59.9.3205-3212.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. De Wit L., Palou M., Content J. Nucleotide sequence of the 85B-protein gene of Mycobacterium bovis BCG and Mycobacterium tuberculosis. DNA Seq. 1994;4(4):267–270. [PubMed] [Google Scholar]
  9. Deretic V., Philipp W., Dhandayuthapani S., Mudd M. H., Curcic R., Garbe T., Heym B., Via L. E., Cole S. T. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol Microbiol. 1995 Sep;17(5):889–900. doi: 10.1111/j.1365-2958.1995.mmi_17050889.x. [DOI] [PubMed] [Google Scholar]
  10. Dessen A., Quémard A., Blanchard J. S., Jacobs W. R., Jr, Sacchettini J. C. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science. 1995 Mar 17;267(5204):1638–1641. doi: 10.1126/science.7886450. [DOI] [PubMed] [Google Scholar]
  11. Garbe T. R., Hibler N. S., Deretic V. Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates. Mol Med. 1996 Jan;2(1):134–142. [PMC free article] [PubMed] [Google Scholar]
  12. Heym B., Zhang Y., Poulet S., Young D., Cole S. T. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J Bacteriol. 1993 Jul;175(13):4255–4259. doi: 10.1128/jb.175.13.4255-4259.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Horwitz M. A., Lee B. W., Dillon B. J., Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1530–1534. doi: 10.1073/pnas.92.5.1530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kremer L., Baulard A., Estaquier J., Content J., Capron A., Locht C. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol. 1995 Feb;177(3):642–653. doi: 10.1128/jb.177.3.642-653.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Quémard A., Lanéelle G., Lacave C. Mycolic acid synthesis: a target for ethionamide in mycobacteria? Antimicrob Agents Chemother. 1992 Jun;36(6):1316–1321. doi: 10.1128/aac.36.6.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Quémard A., Sacchettini J. C., Dessen A., Vilcheze C., Bittman R., Jacobs W. R., Jr, Blanchard J. S. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry. 1995 Jul 4;34(26):8235–8241. doi: 10.1021/bi00026a004. [DOI] [PubMed] [Google Scholar]
  17. Sathyamoorthy N., Takayama K. Purification and characterization of a novel mycolic acid exchange enzyme from Mycobacterium smegmatis. J Biol Chem. 1987 Oct 5;262(28):13417–13423. [PubMed] [Google Scholar]
  18. Wiker H. G., Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev. 1992 Dec;56(4):648–661. doi: 10.1128/mr.56.4.648-661.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wiker H. G., Nagai S., Harboe M., Ljungqvist L. A family of cross-reacting proteins secreted by Mycobacterium tuberculosis. Scand J Immunol. 1992 Aug;36(2):307–319. doi: 10.1111/j.1365-3083.1992.tb03104.x. [DOI] [PubMed] [Google Scholar]
  20. Young D. B., Garbe T. R. Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun. 1991 Sep;59(9):3086–3093. doi: 10.1128/iai.59.9.3086-3093.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zhang Y., Garbe T., Young D. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol. 1993 May;8(3):521–524. doi: 10.1111/j.1365-2958.1993.tb01596.x. [DOI] [PubMed] [Google Scholar]
  22. Zhang Y., Young D. B. Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control. Trends Microbiol. 1993 Jun;1(3):109–113. doi: 10.1016/0966-842x(93)90117-a. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES